
What if the Make America Healthy Again (MAHA) movement isn't political noise—but a powerful signal that patient expectations are fundamentally changing?
In this episode of Med Tech Gurus, we sit down with Noël Theodosiou, CEO of Luminous, to explore the growing trust gap between life sciences companies and the patients they serve. Noël challenges leaders to move beyond a traditional "we know best" mindset and embrace a biopsychosocial, patient-centered approach to innovation.
From GLP-1 adoption trends to AI-driven health searches, we discuss why co-creation, prevention, and clearer separation between science and promotion are critical to rebuilding credibility. For founders, executives, and investors navigating today's shifting healthcare landscape, this conversation delivers practical insight into aligning innovation with modern patient expectations.